J2H-1702
- Generic Name
- J2H-1702
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- J2H Biotech
- Target Recruit Count
- 80
- Registration Number
- NCT06297434
- Locations
- 🇰🇷
J2H Biotech, Suwon, Gyeonggi-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath